| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |